U.S. Gas Utilities Stock News

Investors are scrutinizing regional banks' exposure to private credit after a peer reported a large loan default and write off. This sector wide concern has raised fresh questions about credit risk management practices at institutions such as UMB Financial (NasdaqGS:UMBF). The issue centers on how regional banks underwrite, monitor, and reserve against higher risk private credit loans. For you as an investor, the renewed focus on private credit exposure comes at a time when regional banks...

Voss Capital, a significant shareholder of Euronet Worldwide (NasdaqGS:EEFT), has publicly urged the board to pursue strategic alternatives. The investor cites prolonged underperformance and the value of Euronet's global infrastructure as key reasons for its push. This public call adds activist pressure on the company and may influence future decisions on corporate direction or ownership. Euronet Worldwide operates payments and financial technology infrastructure across multiple regions,...

PACS Group (NYSE:PACS) has appointed Dr. Patrick H. Conway to its Board of Directors. Dr. Conway is a healthcare leader with experience as CEO of Optum and a senior leader at the Centers for Medicare & Medicaid Services. The appointment is intended to support PACS Group’s focus on value-based care and policy expertise in the post-acute sector. PACS Group, listed on the NYSE under the ticker PACS, operates in the post-acute care space, where reimbursement models and regulatory frameworks...

Amer Sports (NYSE:AS) has completed a substantial follow-on equity offering. The transaction included several major financial institutions as co-lead underwriters, including BNP Paribas, UBS, Goldman Sachs, Citigroup, Evercore, and Morgan Stanley. The offering represents a material development for the company’s capital structure and financing plans. Amer Sports, known for its portfolio of sports and outdoor brands, operates at the intersection of performance gear, lifestyle, and...

Super Group (SGHC) announced an increase to its annual dividend program. The company declared its first higher quarterly dividend under the new policy. The move signals a shift in how NYSE:SGHC is approaching shareholder returns. For investors watching NYSE:SGHC, this updated dividend approach comes after a period of mixed share performance. The stock is trading at $10.64, with a 30 day return of 18.4% and a 1 year return of 58.7%, while year to date performance shows an 8.6% decline. Over...

Rigel Pharmaceuticals (RIGL) is back in focus after reporting fourth quarter and full year 2025 results, with revenue of US$69.8 million for the quarter and net income of US$268.07 million. See our latest analysis for Rigel Pharmaceuticals. Despite the strong Q4 and full year 2025 earnings, Rigel Pharmaceuticals' recent share price performance has been weak, with a 90 day share price return of 40.99% and a year to date share price return of 30.98%, while the 1 year total shareholder return of...

Lionsgate Studios, NYSE:LION, is partnering with Scentbird to launch limited-edition fragrances tied to The Twilight Saga and John Wick. The collaboration introduces exclusive scent drops that connect film IP with lifestyle products for fans. Campaigns feature social media activations, experiential marketing, and involvement from original cast members. Lionsgate Studios, NYSE:LION, has long leaned on franchises such as The Twilight Saga and John Wick as key entertainment assets, and this...

Clinical milestones and earnings set the context for Compass Therapeutics stock Compass Therapeutics (CMPX) has been in focus after reaching the planned survival event threshold in its Phase 2/3 COMPANION-002 trial for biliary tract cancer, along with FDA clearance for its CTX-10726 investigational program. These developments come as the company reported a full year 2025 net loss of US$66.49 million and a fourth quarter net loss of US$15.72 million, figures that help frame current...

Versant Media Group, Inc. recently reported full-year 2025 results showing lower sales of about US$6.69 billion and net income of US$930 million, while its board approved a US$0.375 quarterly dividend and authorized up to US$1 billion in share repurchases. Alongside these capital return moves, management is emphasizing disciplined bolt-on acquisitions, a shift toward digital and ad-supported platforms, and maintaining a strong balance sheet as a newly independent media company. Next, we’ll...

Multiple analysts have downgraded Fiverr International (NYSE:FVRR), signaling a reset in sentiment around the platform's business outlook. The Optimist Fund, a major institutional investor and former top holder of FVRR, has fully exited its position. These moves come as the market focuses on Fiverr's customer acquisition challenges and pressure on active buyer trends and revenue expectations. For you as an investor, the reaction in NYSE:FVRR has been sharp. The stock closed at $11.33, with...

The U.S. Department of Justice has opened an investigation into Regencell Bioscience Holdings for potential violations of federal securities laws. Authorities have requested extensive documentation related to the company’s operations, finances, and accounting. Regencell expects substantial legal expenses and acknowledges the possibility of fines or settlements that may not be fully covered by insurance. For shareholders of Regencell Bioscience Holdings, ticker NasdaqCM:RGC, this...

If you are wondering whether JOYY's share price really reflects what the business is worth, you are not alone. This article is going to focus squarely on that question. JOYY recently closed at US$60.80, with returns of 1.9% over 7 days, a 1.8% decline over 30 days, a 6.1% decline year to date, a 33.8% gain over 1 year and a 139.0% gain over 3 years, while the 5 year return stands at a 36.6% decline. These mixed returns have kept investors focused on how sentiment around JOYY is shifting, and...

APi Group (NYSE:APG) reports record revenue levels alongside higher profitability. The company highlights 21 consecutive quarters of double digit inspection growth in North America. Management continues to pursue bolt on acquisitions while expanding free cash flow margins. APi Group, listed on the NYSE under the ticker APG, focuses on safety and specialty services with an inspection first model that aims to drive recurring revenue. Recent updates around record revenue, stronger...

If you are wondering whether Nomad Foods at US$10.33 is starting to look like value or a value trap, you are not alone. That is exactly what this article will unpack. The stock has seen an 8.3% decline over the last week, an 18.0% drop over the past month, and is down 47.0% over the past year, putting long term holders under pressure and raising fresh questions about risk and return. Recent coverage has focused on how prolonged share price weakness and earlier acquisition activity have...

Sprout Social recently reported fourth-quarter 2025 revenue of US$120.89 million and a net loss of US$10.74 million, alongside filing a US$23.19 million shelf registration for 3,573,414 Class A shares tied to its employee stock ownership plans. The combination of improving loss per share, new 2026 revenue guidance, and potential employee share issuance offers fresh insight into how Sprout Social is funding growth and rewarding staff while remaining unprofitable. Against this backdrop of...

Medical Properties Trust (NYSE:MPT) has issued a response to Prospect Medical Group's bankruptcy filing. The company is outlining potential operational impacts related to Prospect's tenant status and leased hospital assets. Investors are watching for updates on rental income exposure, asset utilization, and any changes to existing lease arrangements. Medical Properties Trust focuses on owning and leasing hospital and healthcare facilities, so any disruption involving a key tenant like...

Aardvark Therapeutics (AARD) has put its Phase 3 HERO trial for ARD-101 in Prader-Willi Syndrome on hold after reversible cardiac issues at higher doses, triggering delays, legal scrutiny, and sharp share price swings. See our latest analysis for Aardvark Therapeutics. The HERO trial pause has been the clear driver of volatility, with Aardvark Therapeutics’ 1-day share price return of 15.1% coming after sharp declines, including a 57.6% 30-day share price loss and a 50.4% 1-year total...

Semrush Holdings (NYSE:SEMR) has launched Spotlight 2026, an AI focused marketing conference centered on brand visibility in the AI search era. The company has introduced an official Semrush app within ChatGPT to bring its marketing toolkit into the conversational AI environment. These moves come as Semrush continues through its planned acquisition process with Adobe. Semrush operates as a digital marketing platform, with tools that help businesses manage search visibility, content, and...

Root, Inc. previously reported fourth-quarter 2025 revenue of US$397 million, up from US$326.7 million a year earlier, with net income of US$5.1 million compared with US$20.9 million. For 2025 overall, Root lifted revenue to US$1.52 billion and increased net income to US$38.3 million, but its fourth-quarter profit was lower than the prior year despite higher sales. Next, we’ll examine how Root’s higher full-year revenue and earnings, alongside weaker quarterly profit, may influence its...

YETI Holdings (NYSE:YETI) has appointed Scott Bomar as its new Chief Financial Officer. Bomar joins the company from The Home Depot, bringing financial and operational leadership experience. He succeeds long serving CFO Mike McMullen, marking a key change in YETI's executive team. YETI Holdings, known for its premium coolers, drinkware and outdoor gear, sits at the intersection of consumer brands and the broader outdoor recreation and lifestyle market. For investors watching branded...

Omnicell, ticker NasdaqGS:OMCL, is shifting its focus toward a software and services led model. The company recently acquired ANiGENT to deepen its capabilities in drug diversion detection within healthcare settings. This move marks a meaningful step in Omnicell's transition from a hardware vendor to a Healthcare IT company. Omnicell's pivot comes after a mixed share price record, with the stock at $41.53 and a value score of 4. The shares show a 9.8% gain over the past year, while longer...

Accel Entertainment (ACEL) has wrapped up FY 2025 with fourth quarter revenue of US$341.4 million and EPS of US$0.19, capping a year in which trailing twelve month revenue reached US$1.3 billion and EPS came in at US$0.61. The company has seen quarterly revenue move from US$302.2 million in Q3 2024 to US$341.4 million in Q4 2025, while quarterly EPS stepped up from US$0.06 to US$0.19 over the same stretch, setting the backdrop for investors focused on earnings growth and profit consistency...

SoundThinking (SSTI) has just closed out FY 2025 with fourth quarter revenue of US$24.8 million and a basic EPS loss of US$0.22, capping a trailing twelve month run of US$104.1 million in revenue and a total EPS loss of US$0.74. Over the past year, the company has reported quarterly revenue between US$24.8 million and US$28.3 million, while quarterly basic EPS has ranged from a loss of US$0.12 to US$0.25. This sets up a results season in which investors may pay less attention to changes in...

Century Aluminum (NasdaqGS:CENX) disclosed a delay in filing its next 10-K with the SEC. The filing delay comes shortly after significant executive insider stock sales. The company also recently announced a major partnership to build a domestic aluminum smelter. For a company that is closely watched by equity investors, the timing of these developments is hard to ignore. Century Aluminum, trading at $52.92, has posted a 29.3% return year to date and a 189.8% return over the past year, with...